Přihlásit se Zaregistrujte se zdarma

1letý cíl společnosti AMAG Pharmaceuticals

Jaká je hodnota metriky 1letý cíl společnosti AMAG Pharmaceuticals?

Hodnota metriky 1letý cíl společnosti AMAG Pharmaceuticals, Inc. je $13 -47.52%

Jaká je definice metriky 1letý cíl?

1-letý cíl (1-year target) je analytiky předpokládaná cena akcie za rok od dnešního dne.

One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.

1letý cíl společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností AMAG Pharmaceuticals

Čemu se věnuje společnost AMAG Pharmaceuticals?

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.

Firmy s metrikou 1letý cíl podobnou společnosti AMAG Pharmaceuticals